全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

查看量下载量

相关文章

更多...

对2019年新型冠状病毒肺炎的认识及我国的疫情防控措施
Understanding of 2019 New Coronavirus Pneumonia and Epidemic Prevention and Control Measures in China

DOI: 10.12677/ACM.2020.109299, PP. 1996-2001

Keywords: COVID-19，新型冠状病毒，公共卫生干预
COVID-19, Novel Coronavirus, Public Health Intervention

Full-Text   Cite this paper   Add to My Lib

Abstract:

2019年12月以来，从武汉出现一系列原因不明的肺炎病例开始，我国各地陆续出现新型冠状病毒肺炎疫情的蔓延，渐成为国际关注的突发公共卫生事件。2020年1月12日，世界卫生组织将这种新病毒暂时命名为2019年新型冠状病毒(2019-nCoV)。2020年1月20日我国将其纳入乙类传染病并按甲类进行管理。2020年1月30日，世界卫生组织宣布2019-nCoV疫情是国际关注的突发公共卫生事件(PHEIC)。2020年2月11日，世卫组织正式将2019-nCoV引起的疾病命名为冠状病毒病(COVID-19)。就目前资料对COVID-19的流行病学及临床表现进行认识，同时对我国面对疫情的防控措施进行阐述。
Since December 2019, a series of unexplained pneumonia cases have emerged in Wuhan, and the new coronavirus pneumonia epidemic has spread in various parts of China, gradually becoming a public health emergency of international concern. On January 12, 2020, the World Health Organization tentatively named the new virus the new coronavirus of 2019 (2019-ncov). On January 20, 2020, China included it in Class B infectious diseases and managed it according to Class A. On 30 January 2020, the World Health Organization declared the 2019-ncov outbreak a public health emergency of international concern (PHEIC). On 11 February 2020, WHO officially named the disease caused by 2019-ncov as coronavirus disease (covid-19). Based on the current data, the epidemiological and clinical manifestations of COVID-19 were understood, and the prevention and control measures against the epidemic in China were expounded.

References

[1]  Huang, C., Wang, Y., Li, X., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497-506.
https://doi.org/10.1016/S0140-6736(20)30183-5
[2]  Dong, N., Yang, X., Ye, L., et al. (2020) Genomic and Protein Structure Modelling Analysis Depicts the Origin and Infectivity of 2019-nCoV, a New Coronavirus Which Caused a Pneumonia Outbreak in Wuhan, China.
https://doi.org/10.1101/2020.01.20.913368
[3]  Randhawa, G.S., Soltysiak, M.P.M., Roz, H.E., et al. (2020) Machine Learning Using Intrinsic Genomic Signatures for Rapid Classification of Novel Pathogens: COVID-19 Case Study.
https://doi.org/10.1101/2020.02.03.932350
[4]  Ji, W., Wang, W., Zhao, X., et al. (2020) Cross-Species Transmission of the Newly Identified Coronavirus 2019-nCoV. Journal of Medical Virology, 92, 433-440.
https://doi.org/10.1002/jmv.25682
[5]  Li, X., Wang, W., Zhao, X., et al. (2020) Transmission Dynamics and Evolutionary History of 2019-nCoV. Journal of Medical Virology.
https://doi.org/10.1002/jmv.25701
[6]  Kang, M., Wu, J., Ma, W., et al. (2020) Evidence and Characteristics of Human-to-Human Transmission of SARS-CoV-2.
[7]  Sun, K., Chen, J. and Viboud, C. (2020) Early Epidemiological Analysis of the 2019-nCoV Outbreak Based on a Crowd Sourced Data.
[8]  Lauer, S.A., Grantz, K.H., Bi, Q., et al. (2020) The Incubation Period of 2019-nCoV from Publicly Reported Confirmed Cases: Estimation and Application.
[9]  Backer, J.A., Klinkenberg, D. and Wallinga, J. (2020) The Incubation Period of 2019-nCoV Infections among Travellers from Wuhan, China.
https://doi.org/10.1101/2020.01.27.20018986
[10]  Chen, N., Zhou, M., Dong, X., et al. (2020) Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. The Lancet, 395, 507-513.
https://doi.org/10.1016/S0140-6736(20)30211-7
[11]  国际合作司. 世界卫生组织宣布新型冠状病毒感染的肺炎疫情构成“国际关注的突发公共卫生事件”: 不建议对中国采取旅行和贸易限制[EB/OL]. http://www.nhc.gov.cn/gjhzs/s7952/202001/b196e4f678bc4447a0e4440f92dac81b.shtml
[12]  Gilbert, M., Pullano, G., Pinotti, F., et al. (2020) Preparedness and Vulnerability of African Countries against Introductions of 2019-nCoV.
https://doi.org/10.1101/2020.02.05.20020792
[13]  Du, Z., Wang, L., Cauchemez, S., et al. (2020) Risk for Transportation of 2019 Novel Coronavirus Disease from Wuhan to Other Cities in China. Emerging Infectious Diseases, 26, 1049-1052.
https://doi.org/10.3201/eid2605.200146
[14]  疾病预防控制局. 关于印发新型冠状病毒感染不同风险人群防护指南和预防新型冠状病毒感染的肺炎口罩使用指南的通知[EB/OL]. http://www.nhc.gov.cn/jkj/s7916/202001/a3a261dabfcf4c3fa365d4eb07ddab34.shtml
[15]  疾病预防控制局. 关于印发公共场所新型冠状病毒感染的肺炎卫生防护指南的通知[EB/OL]. http://www.nhc.gov.cn/jkj/s7916/202001/d9ae8301384a4239a8041d6f77da09b6.shtml
[16]  Kucharski, A.J., Russell, T.W., Diamond, C., et al. (2020) Early Dynamics of Transmission and Control of COVID-19: A Mathematical Modelling Study.
https://doi.org/10.1101/2020.01.31.20019901
[17]  Muniz-Rodriguez, K., Chowell, G., Cheung, C.-H., et al. (2020) Epidemic Doubling Time of the COVID-19 Epidemic by Chinese Province.
https://doi.org/10.1101/2020.02.05.20020750
[18]  Ming, W.-K., Huang, J. and Zhang, C.J.P. (2020) Breaking Down of Healthcare System: Mathematical Modelling for Controlling the Novel Coronavirus (2019-nCoV) Outbreak in Wuhan, China.
https://doi.org/10.1101/2020.01.27.922443
[19]  Chen, L., Liu, W., Zhang, Q., et al. (2020) RNA Based mNGS Approach Identifies a Novel Human Coronavirus from Two Individual Pneumonia Cases in 2019 Wuhan Outbreak. Emerging Microbes & Infections, 9, 313-319.
https://doi.org/10.1080/22221751.2020.1725399
[20]  Yuan, H.-Y., Hossain, M.P., Tsegaye, M.M., et al. (2020) Estimating the Risk on Outbreak Spreading of 2019-nCoV in China Using Transportation Data.
[21]  Tian, H., Liu, Y., Li, Y., et al. (2020) Early Evaluation of Transmission Control Measures in Response to the 2019 Novel Coronavirus Outbreak in China.
[22]  Xu, X., Chen, P., Wang, J., et al. (2020) Evolution of the Novel Coronavirus from the Ongoing Wuhan Outbreak and Modeling of Its Spike Protein for Risk of Human Transmission. Science China Life Sciences.
https://doi.org/10.1007/s11427-020-1637-5
[23]  WHO (2020) Novel Coronavirus—China. http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en
[24]  疾病预防控制局. 中华人民共和国国家卫生健康委员会公告: 2020年第1号[EB/OL]. http://www.nhc.gov.cn/jkj/s7916/202001/44a3b8245e8049d2837a4f27529cd386.shtml?from=singlemessage&wYNOrhhjiR4y=1583455634772
[25]  国家卫生健康委. 国家卫生健康委关于修订新型冠状病毒肺炎英文命名事宜的通知[EB/OL]. http://www.nhc.gov.cn/xcs/zhengcwj/202002/6ed7614bc35244cab117d5a03c2b4861.shtml
[26]  Riou, J. and Althaus, C.L. (2020) Pattern of Early Human-to-Human Transmission of Wuhan 2019-nCoV.
https://doi.org/10.1101/2020.01.23.917351
[27]  Ai, S., Zhu, G., Tian, F., et al. (2020) Population Movement, City Closure and Spatial Transmission of the 2019-nCoV Infection in China.
https://doi.org/10.1101/2020.02.04.20020339
[28]  Wu, J.T., Leung, K. and Leung, G.M. (2020) Nowcasting and Forecasting the Potential Domestic and International Spread of the 2019-nCoV Outbreak Originating in Wuhan, China: A Modelling Study. The Lancet, 395, 689-697.
https://doi.org/10.1016/S0140-6736(20)30260-9
[29]  Chan, J.F., Yuan, S., Kok, K.H., et al. (2020) A Familial Cluster of Pneumonia Associated with the 2019 Novel Coronavirus Indicating Person-to-Person Transmission: A Study of a Family Cluster. The Lancet, 395, 514-523.
https://doi.org/10.1016/S0140-6736(20)30154-9
[30]  Guo, Q., Li, M., Wang, C., et al. (2020) Host and Infectivity Prediction of Wuhan 2019 Novel Coronavirus Using Deep Learning Algorithm.
https://doi.org/10.1101/2020.01.21.914044
[31]  Zhu, N., Zhang, D., Wang, W., et al. (2020) A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine, 382, 727-733.
https://doi.org/10.1056/NEJMoa2001017
[32]  Li, F. (2012) Evidence for a Common Evolutionary Origin of Coronavirus Spike Protein Receptor-Binding Subunits. Journal of Virology, 86, 2856-2858.
https://doi.org/10.1128/JVI.06882-11
[33]  Schoeman, D. and Fielding, B.C. (2019) Coronavirus Envelope Protein: Current Knowledge. Virology Journal, 16, 69.
https://doi.org/10.1186/s12985-019-1182-0
[34]  Xu, X., Chen, P., Wang, J., et al. (2020) Evolution of the Novel Coronavirus from the Ongoing Wuhan Outbreak and Modeling of Its Spike Protein for Risk of Human Transmission. Science China Life Sciences, 63, 457-460.
https://doi.org/10.1007/s11427-020-1637-5
[35]  Lu, R., Zhao, X., Li, J., et al. (2020) Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding. The Lancet, 395, 565-574.
https://doi.org/10.1016/S0140-6736(20)30251-8
[36]  Boldog, P., Tekeli, T., Vizi, Z., et al. (2020) Risk Assessment of Novel Coronavirus COVID-19 Outbreaks outside China.
https://doi.org/10.1101/2020.02.04.20020503
[37]  He, X., Zhang, L., Ran, Q., et al. (2020) Integrative Bioinformatics Analysis Provides Insight into the Molecular Mechanisms of 2019-nCoV.
https://doi.org/10.1101/2020.02.03.20020206

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133